Connor, Clark & Lunn Investment Management (CC&L)
BBIO icon

Connor, Clark & Lunn Investment Management (CC&L)’s BridgeBio Pharma BBIO Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
2025
Q1 		$1.25M Buy
2024
Q4 		– Sell
2024
Q3 		$309K Buy
2022
Q4 		– Sell
2022
Q3 		$499K Buy
2022
Q2 		$153K Sell
2022
Q1 		$3.73M Buy